Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omar El Merhebi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biosensors|September 27, 2023
Cost-Effective Modular Biosensor for SARS-CoV-2 and Influenza A DetectionAndrew Murray, Julio Ojeda, Omar El Merhebi, et al.
Cell Reports|July 13, 2023
Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccineFelipe Lopes de Assis, Kenneth B Hoehn, Xiaozhen Zhang, et al.
Cell Reports|April 13, 2025
Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infectionLela Kardava, James Lim, Clarisa M Buckner, et al.
Cell|October 18, 2022
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responsesClarisa M Buckner, Lela Kardava, Omar El Merhebi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 12, 2022
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccinationClarisa M Buckner, Lela Kardava, Omar El Merhebi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biosensors|September 27, 2023
Cost-Effective Modular Biosensor for SARS-CoV-2 and Influenza A DetectionAndrew Murray, Julio Ojeda, Omar El Merhebi, et al.
Cell Reports|July 13, 2023
Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccineFelipe Lopes de Assis, Kenneth B Hoehn, Xiaozhen Zhang, et al.
Cell Reports|April 13, 2025
Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infectionLela Kardava, James Lim, Clarisa M Buckner, et al.
Cell|October 18, 2022
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responsesClarisa M Buckner, Lela Kardava, Omar El Merhebi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 12, 2022
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccinationClarisa M Buckner, Lela Kardava, Omar El Merhebi, et al.
Pageof 1